List Biological Laboratories

Campbell, United States Founded: 1978 • Age: 48 yrs Acquired By Genome & Company
Specializes in the production of research reagents

About List Biological Laboratories

List Biological Laboratories is a Healthcare company based in Campbell (United States) founded in 1978, and was acquired by Genome & Company in September 2021. It specializes in the production of research reagents. List Biological Laboratories has raised $48.4 million across 2 funding rounds from investors including Korea Investment Holdings, Genome & Company and DSC Investment. List Biological Laboratories offers products and services including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is LIST BIOLOGICAL LABORATORIES, INC. Its competitors include PrognomiQ, ACRO Biosystems and Ansh Labs; 1 of its 3 listed competitors has raised funding.

Company details

Specializes in the production of reagents for research and custom laboratory services. The company product line includes anthrax toxins, antisera antibodies, botulinum toxins, cholera toxins, clostridial toxins, other difficile toxins, Diphtheria Toxin CRM Exotoxin, Peptides, Native Substrates Receptors, Lipopolysaccharides, Pertussis Toxins Virulence Factors, Shiga Toxins, Staphylococcal Toxins, Tetanus Toxins Related Products, Toxoids Vaccine Carrier Proteins and Adjuvants.

  • Headquarters Campbell, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website listlabs.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Genome & Company (Sep 2021)
  • Legal Name List Biological Laboratories, Inc
Key Metrics

Products & Services of List Biological Laboratories

List Biological Laboratories offers a comprehensive portfolio of products and services, including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics.

Bacterial Toxins
Research Reagents

High-purity toxins for disease studies and therapeutic tools.

Bacterial Polysaccharides
Biomaterials

Compounds for vaccine development and research applications.

Recombinant Proteins
Biotech Products

Proteins for clinical and research use in therapies.

Live Biotherapeutics
CDMO Services

Manufacturing for microbiome-based therapeutic products.

Apps and channels of List Biological Laboratories

its YouTube channel List Biological Laboratories, Inc. has 32 subscribers and 10 videos.

List Biological Laboratories, Inc.
YouTube 32 subscribers 10 videos Science & Technology
Open channel

Videos from List Biological Laboratories

The most watched videos on List Biological Laboratories's YouTube channel, List Biological Laboratories, Inc. (32 subscribers). Click a video to play it here.

How To Open DG Containers And Vials
4.4K views
Microbiome and Live Biotherapeutic Expertise - List Labs
600 views
Overcoming Obstacles in the development of Live Biotherapeutic Products
428 views
CDMO for Pharma: Supporting the Development & Manufacturing of Microbiome Therapeutic Products
392 views

More on List Biological Laboratories, Inc..

Funding Insights of List Biological Laboratories

List Biological Laboratories has successfully raised a total of $48.4M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $17.4 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $48.4M
  • Total Rounds 2
  • Last Round Private Equity Round β€” $17.4M
  • First Round $31M

    (Dec 2021)

  • Investors Count 3

All 2 funding rounds of List Biological Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2022$17.4MPrivate Equity Round––
–
Dec 2021$31MPrivate Equity Round–DSC Investment, Korea Investment Holdings
–
Valuation history

4 investors in total: 4 institutional.

Investors in List Biological Laboratories

List Biological Laboratories has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Korea Investment Holdings, Genome & Company and DSC Investment.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage venture capital is invested primarily in South Korean startups.
2012dscinvestment.comSeoul, South Korea
Investment holding firm established in Seoul in 2003.
2003koreainvestment.comSeoul, South Korea
Operates as an investment management firm handling diversified funds and portfolios.
2006koreavalueasset.comSeoul, South Korea
Microbiome-based immuno-oncology drugs are developed using proprietary technology.
2015genomecom.co.krSeongnam-si, South Korea
Premium access

Investor details for List Biological Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of List Biological Laboratories

12 people are tracked at List Biological Laboratories (4 in leadership, 8 in team).

NameRoleGroup
Gary Henderson
Director Of Sales And Business DevelopmentLeadership
Nuria Gonzalez Montalban
Director Of Biologics DevelopmentLeadership
Stacy Burns-Guydish
PresidentLeadership
Joseph Yu
Sr. Director, Development And ManufacturingLeadership
Steven Elayda
Manufacturing Associate Iii, PurificationTeam
Shivangi Darji
Microbiologist IITeam
Carina Rocchio
Laboratory ManagerTeam
Mary Nguyen
Fermentation Specialist IITeam
Matthew Aguilar
Production Biochemist 2Team
Kendall Kato
Production Operations ManagerTeam
Todd Christian
Process Development ManagerTeam
Monica Straube
Fermentation Specialist IIITeam
Premium access

Complete people profiles for List Biological Laboratories

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of List Biological Laboratories

4 dated milestones of List Biological Laboratories across 44 years, from founding to its latest funding, stage changes and deals.

  1. Founded List Biological Laboratories is founded.
  2. Exit Acquired by Genome & Company.
  3. Funding First funding round of $31.0M.
  4. Funding Latest funding round, Private Equity Round, of $17.4M.

Competitors of List Biological Laboratories

List Biological Laboratories has 3 listed competitors in our database, 1 of them funded. They include PrognomiQ, ACRO Biosystems and Ansh Labs.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
prognomiq.com2020San Mateo, United States$90.36M24
Developer of tests for the detection and treatment of cancer and other diseases
acrobiosystems.com2016Newark, United States22
Recombinant proteins are manufactured to support cancer immunotherapy efforts.
anshlabs.com2010Webster, United States33
Immunoassay reagents and kits are developed for life science research.
Premium access

Detailed competitors of List Biological Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of List Biological Laboratories

The website of List Biological Laboratories (listlabs.com) receives about 7.6K visits a month.

  • Monthly visits
    7.6K

    ▲ 17.9% vs previous month

Similar websites

Websites whose visitors overlap most with List Biological Laboratories. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biologylab.awlonline.com
biologylab.awlonline.com
100%
–
abdesignlabs.com
97%
4.7K#4,128,811View details
bioscience.co.uk
92%
58K#534,137View details
lampire.com
86%
#2,833,014View details
embl.org
86%
302.2K#140,553View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 15 similar websites and full traffic analytics for List Biological Laboratories

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as List Biological Laboratories (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about List Biological Laboratories

Premium access

Complete news archive for List Biological Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about List Biological Laboratories

List Biological Laboratories was founded in 1978 and raised its 1st funding round 43 years after it was founded.

List Biological Laboratories is headquartered in Campbell, United States. It is registered at Campbell, California, United States.

List Biological Laboratories is a funded company, having raised a total of $48.4M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $31M, raised on Dec 2021.

Specializes in the production of reagents for research and custom laboratory services. The company product line includes anthrax toxins, antisera antibodies, botulinum toxins, cholera toxins, clostridial toxins, other difficile toxins, Diphtheria Toxin CRM Exotoxin, Peptides, Native Substrates Receptors, Lipopolysaccharides, Pertussis Toxins Virulence Factors, Shiga Toxins, Staphylococcal Toxins, Tetanus Toxins Related Products, Toxoids Vaccine Carrier Proteins and Adjuvants.

List Biological Laboratories's top competitors include PrognomiQ, ACRO Biosystems and Ansh Labs.

List Biological Laboratories offers Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics.

List Biological Laboratories has 4 investors. Key investors include Korea Investment Holdings, Genome & Company, DSC Investment, and Korea Investment Value Asset Management.

List Biological Laboratories operates through List Biological Laboratories, Inc.

Yes. List Biological Laboratories was acquired by Genome & Company in September 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available